Divis Laboratories Ltd | DIVI - Trade Creditors

Stock Price
6,760.50
Daily Change
-161.00 -2.33%
Monthly
7.42%
Yearly
7.66%
Q2 Forecast
6,615.83

Divis Laboratories Ltd reported INR10.4B in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Alaunos Therapeutics USD 400K 213K Mar/2026
Aurobindo Pharma INR 47.51B 5.62B Sep/2025
Avita Medical AUD 8.96M 1.69M Dec/2025
Dianthus Therapeutics USD 5.27M 4.45M Mar/2026
Divis Laboratories Ltd INR 10.4B 1.3B Sep/2025
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
IQVIA Holdings USD 3.64B 112M Mar/2026
Lupin INR 41.73B 7.66B Mar/2026
Moderna USD 161M 156M Mar/2026
Organon & Co USD 983M 31M Mar/2026
Revvity USD 169.68M 15.78M Mar/2026
Tectonic Therapeutic USD 2.55M 1.46M Mar/2026
Tilray USD 114.5M 3.69M Sep/2025
Viatris USD 1.2B 93.9M Mar/2026
Xeris Pharmaceuticals USD 11.47M 8.39M Mar/2026